Haematology

Inpatient work is mainly high dose chemotherapy regimens – ESHAP, AML induction, IDA-RAM, High dose Methotrexate, to name but a few. We also see neutropenic sepsis, other complications of chemotherapy and acute presentations of malignancy. The SHO also sees patients on the Chemotherapy Day Unit, and is encouraged to come to clinic on a weekly basis. There are two consultant-led ward rounds per week, and the consultants appreciate that this is a highly specialist group of diagnoses and are happy to come to the ward at any point outside of official ward round slots.

We see a wide range of malignancies, ranging from Chronic lymphocytic leukaemia, B and T cell Non Hodgkins lymphomas, Hodgkin disease, Myeloma, Hairy cell leukaemia, Chronic Myeloid leukaemia, Chronic Myelomonocytic leukaemia, Myeloproliferative disorders, Aplastic anaemia and paroxysmal nocturnal haematuria, Myelodysplastic syndrome and acute myeloid leukaemia. These are mainly managed with out-patient chemotherapy which is administered at Godstone chemotherapy day unit, Comet day unit at Crawley Hospital, and, rarely at home.

Non malignant work includes a large anticoagulant service with 1500 patients on warfarin, and a high throughput of complex thrombotic issues that we see in clinic. We also see conditions including neutropenia, Monoclonal gammopathy of uncertain significance, Immune Thrombocytopenic Purpura, Thrombotic Thrombocytopenic Purpura, Haemolytic Uraemic Syndrome, Hereditary red cell disorders, and a vast range of Bleeding disorders.

We also run a one stop shop for IV iron in iron deficiency at Comet Ward in Crawley.

Dr Ben Field was appointed consultant in diabetes, endocrinology and general medicine at SaSH in March 2012. He is responsible for inpatients on Bletchingley and Hazelwood wards and holds outpatient clinics at East Surrey Hospital and Crawley Hospital. He is the Trust’s RCP tutor for medicine.

He gained a first class BMedSci before graduating in medicine with distinction from St Bartholomew’s Hospital, London, in 1997. After specialist training at Guy’s and St. Thomas’ hospitals, he joined Imperial College London as an MRC clinical research training fellow, obtaining a PhD in 2009 for research into the neuroendocrine control of appetite, energy expenditure and insulin secretion. He is actively involved in research at SaSH and Imperial College, and is an honorary clinical senior lecturer at Imperial College London.

His interests encompass all aspects of diabetes and endocrinology, including structured education in type 1 diabetes mellitus, intensification of insulin treatment, insulin pump therapy, complex type 2 diabetes mellitus, diabetic foot disease, PCOS, pituitary diseases, thyroid, parathyroid and adrenal gland disorders.